Physical Exercise and Neuroinflammation in Major Depressive Disorder

Area of Science:

• Neuroscience
• Psychiatry
• Exercise Physiology

Background:

• Major depressive disorder (MDD) is a widespread condition with variable outcomes and reduced quality of life.
• Heterogeneous patient responses to current treatments contribute significantly to the burden of MDD.
• Inflammation and neuroinflammation are implicated as key biological triggers for MDD.

Purpose of the Study:

• To review the therapeutic effects of physical exercise on major depressive disorder (MDD).
• To elucidate the biological mechanisms linking exercise, neuroinflammation, and MDD pathophysiology.
• To emphasize the interplay between exercise, the hypothalamic-pituitary-adrenal (HPA) axis, and neurotransmitter systems in MDD.

Main Methods:

• Review of experimental protocols in human and animal models.
• Analysis of studies on the effects of physical exercise on inflammation and neuroinflammation.
• Examination of exercise-induced molecular changes, including PGC1α gene expression and kynurenine metabolism.

Main Results:

• Physical exercise demonstrates efficacy comparable to standard therapies for mild to moderate depression.
• Exercise promotes a shift from pro-inflammatory to anti-inflammatory states in the periphery and central nervous system.
• Exercise influences PGC1α expression, kynurenine metabolism, and monoaminergic neurotransmission, potentially mitigating neurotoxicity and inflammation.

Conclusions:

• Physical exercise is a viable therapeutic option for MDD, impacting key biological pathways.
• Exercise modulates neuroinflammation and the HPA axis, offering a mechanism-based approach to depression treatment.
• Understanding these interactions provides insights into novel therapeutic strategies for MDD.